High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...
MD Anderson at Cooper has expanded its prostate cancer treatment program with the addition of robotic high-intensity focused ultrasound, a groundbreaking therapy designed to treat tumors without ...
A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...
High-intensity focused ultrasound (HIFU) is a potentially effective treatment of localized prostate cancer (PCa) that is associated with a low PCa-specific mortality rate, according to researchers. It ...
PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...
First multinational initiative dedicated to long-term HIFU outcomes in prostate cancer and BPH aims to help close the evidence gap in incision-free prostate care ...
Prostate cancer treatment options include radical prostatectomy, radiation therapy, and minimally invasive techniques like cryoablation, HIFU, and TULSA. Minimally invasive therapies generally have ...
Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...
, May 14, 2026 (GLOBE NEWSWIRE) -- AUSTIN, Texas – May 14, 2026 – EDAP TMS S.A. (Nasdaq: EDAP) today announced that it has entered into a letter of intent with Telix Pharmaceuticals Limited (“Telix”) ...